Pantoprazolo Aristo Pharma (Pantoprazole Sodium Sesquihydrate)

Pantoprazole, the active ingredient in Pantoprazolo Aristo Pharma, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease and related acid‑related disorders in adults.

GNH USA supplies Pantoprazolo Aristo Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazolo Aristo Pharma, a proton pump inhibitor, acts on the gastric H+/K+ ATPase to lower acid production.

- Gastro‑oesophageal reflux disease (GERD): relieves heartburn and promotes healing of the oesophageal mucosa. - Erosive oesophagitis: facilitates ulcer healing in the oesophagus. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumours. - Peptic ulcer disease: aids ulcer healing and reduces recurrence risk. - Helicobacter pylori eradication (as part of combination therapy): enhances the effectiveness of antibiotic regimens.

Pantoprazolo Aristo Pharma may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: loose stools occurring during treatment. - Abdominal pain: discomfort or cramping in the stomach area. - Nausea: feeling of sickness or urge to vomit. - Flatulence: increased intestinal gas. - Constipation: difficulty passing stools.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: severe diarrhoea due to bacterial overgrowth. - Low magnesium levels: muscle cramps, weakness, or irregular heartbeat. - Liver enzyme elevation: signs of hepatic dysfunction. - Interstitial nephritis: kidney inflammation presenting with fever and rash. - Stevens‑Johnson syndrome: serious skin and mucous membrane disorder.

Before initiating therapy with Pantoprazolo Aristo Pharma, consider the following precautions. - Renal function assessment: adjust use in patients with severe kidney disease. - Magnesium monitoring: check serum levels during prolonged treatment. - Hepatic impairment: use with caution in patients with liver disease. - Drug interactions: review concomitant medications for potential interactions. - Rebound acid hypersecretion: advise gradual discontinuation to avoid symptom recurrence. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazolo Aristo Pharma can interact with several medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption leading to sub‑therapeutic levels. - High‑dose methotrexate: increased toxicity due to reduced renal clearance.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer monitoring. - Digoxin: elevated serum concentrations may occur. - Diazepam: enhanced sedative effect, necessitating dose adjustment.